Congo vs Luxembourg: Previously treated cases tested for RR-/MDR-TB
Congo
100.0%
in 2024
Luxembourg
100.0%
in 2024
Congo rank
1st
Luxembourg rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Congo
- Luxembourg
How they compare
Congo currently reports 100.0% against 100.0% in Luxembourg, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2020 it was Luxembourg ahead.
Congo ranks 1st and Luxembourg ranks 1st of 180 countries.
Luxembourg has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo or Luxembourg?
- Congo, at 100.0% against 100.0% in Luxembourg as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo and Luxembourg?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Luxembourg?
- 5 years are reported by both, from 2020 to 2024.
- How do Congo and Luxembourg rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo ranks 1st and Luxembourg ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.